2013 annual financial data
BioCryst Pharmaceuticals 2013 Operating margin
BioCryst Pharmaceuticals 2013 operating margin with verified reported values.
Direct answer
Operating margin was -177.24%.
Operating income was -30,717,000 USD and net income was -30,108,000 USD.
Operating cash flow was -26,530,000 USD.
Get free BioCryst Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 17,331,000 USD
- Operating income
- -30,717,000 USD
- Net income
- -30,108,000 USD
- Operating cash flow
- -26,530,000 USD